NP49425 Generic and Biosimilar Transition Medicines
The Authority seeks to establish a Framework Agreement covering medicines that are imminently approaching or have already reached Loss of Exclusivity (LoE). The range of medicines under consideration for inclusion in the Framework Agreement are listed below (subject to removal or replacement due to a continually shifting litigation landscape): - Apremilast 30mg tablets - Axitinib 1mg tablets - Axitinib 3mg tablets - Axitinib 5mg tablets - Axitinib 7mg tablets - Betaine oral powder - Denosumab 120mg/1.7ml solution f...
Buyer
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Value
£131,244,104
Published
5 Aug 2025
Closes
5 Aug 2025
Procurement details
Source
Pcs
Region
Scotland
Procurement method
Not provided
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33600000
Pharmaceutical products
Lots
Lot 8 Cancer Medicines (Group 2)
Value not provided
Supply of cancer medicines (Group 2) to NHS Scotland. The Authority intends to award this Lot as an unranked multi supplier Framework Agreement per product line. Full details of Goods and volumes will be found within the ITT documents once published.
Delivery: Scotland
Lot 1 Cytokine Modulators
Value not provided
Supply of cytokine modulators to NHS Scotland. The Authority intends to award this Lot as an unranked multi supplier Framework Agreement per product line. Full details of Goods and volumes will be found within the ITT documents once published.
Delivery: Scotland
Lot 2 Gastrointestinal, Endocrine, Nutrition, Blood, and Multiple Sclerosis Medicines
Value not provided
Supply of gastrointestinal, endocrine, nutrition, blood, and multiple sclerosis medicines NHS Scotland. The Authority intends to award this Lot as a ranked multi supplier Framework Agreement per product line. Full details of Goods and volumes will be found within the ITT documents once published.
Delivery: Scotland
Lot 3 Denosumab (osteoporosis)
Value not provided
Supply of denosumab (osteoporosis) to NHS Scotland. The Authority intends to award this Lot as an unranked multi supplier Framework Agreement per product line. Full details of Goods and volumes will be found within the ITT documents once published.
Delivery: Scotland
Lot 4 Apremilast
Value not provided
Supply of apremilast to NHS Scotland. The Authority intends to award this Lot as a ranked multi supplier Framework Agreement per product line. Full details of Goods and volumes will be found within the ITT documents once published.
Delivery: Scotland
Lot 5 Cardiovascular and Respiratory Medicines
Value not provided
Supply of cardiovascular and respiratory medicines to NHS Scotland. The Authority intends to award this Lot as a ranked multi supplier Framework Agreement per product line. Full details of Goods and volumes will be found within the ITT documents once published.
Delivery: Scotland
Lot 6 Nintedanib
Value not provided
Supply of nintedanib to NHS Scotland. The Authority intends to award this Lot as a ranked multi supplier Framework Agreement per product line. Full details of Goods and volumes will be found within the ITT documents once published.
Delivery: Scotland
Lot 7 Cancer Medicines (Group 1)
Value not provided
Supply of cancer medicines (Group 1) to NHS Scotland. The Authority intends to award this Lot as a ranked multi supplier Framework Agreement per product line. Full details of Goods and volumes will be found within the ITT documents once published.
Delivery: Scotland
Lot 9 Neurology Medicines
Value not provided
Supply of neurology medicines to NHS Scotland. The Authority intends to award this Lot as a ranked multi supplier Framework Agreement per product line. Full details of Goods and volumes will be found within the ITT documents once published.
Delivery: Scotland
Documents
Unlock document linkNP49425 Generic and Biosimilar Transition Medicines
Not provided
The Authority seeks to establish a Framework Agreement covering medicines that are imminently approaching or have already reached Loss of Exclusivity (LoE). The range of medicines under consideration for inclusion in the Framework Agreement...
Planned procurement notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.